A summit focused on Glucose Transporter 1 deficiency and its impacts.
The 11th international Glut1 deficiency summit
This study is bringing together scientists, patients, and advocates to share ideas and improve understanding of Glucose Transporter 1 deficiency (G1D), a condition that can cause epilepsy and learning challenges, with the goal of finding better treatments and support for those affected.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Weill Medical Coll of Cornell Univ NIH-funded |
| Lab location | 1 site (New York, United States) |
| Project ID | NIH-10999935 on NIH RePORTER |
What this research studies
This research brings together scientists, patients, and advocates to discuss Glucose Transporter 1 deficiency (G1D), a condition linked to epilepsy and intellectual disabilities. The summit aims to share knowledge and foster collaboration among experts to enhance understanding and treatment options for G1D. By harmonizing the voices of the scientific community and patient organizations, the initiative seeks to propel advancements in research and patient care. The event will also highlight recent findings and potential therapeutic approaches, including dietary treatments.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with Glucose Transporter 1 deficiency or those experiencing related symptoms such as epilepsy or intellectual disabilities.
Not a fit: Patients with conditions unrelated to Glucose Transporter 1 deficiency may not receive any benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved understanding and potential treatment options for patients with Glucose Transporter 1 deficiency.
How similar studies have performed: Previous research efforts in the field have shown promise, indicating that collaborative approaches can yield significant advancements in understanding and treating G1D.
Where this research is happening
New York, United States
- Weill Medical Coll of Cornell Univ — New York, United States (Active)
Researchers
- Principal investigator: Pascual, Juan M. — Weill Medical Coll of Cornell Univ
- Study coordinator: Pascual, Juan M.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.